Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Thursday, April 2, 2020 · 513,640,547 Articles · 3+ Million Readers

COVID-19: How R&D Responded and What We Learned for Future Outbreaks

Cover image of the second COVID-19 report

Cover image of the second COVID-19 report

New reports track the epidemiology of the COVID-19 pandemic and details current global responses in addition to how the R&D industry is reacting

The COVID-19 pandemic has been growing at such a speed that no region in the world will be left unaffected.”
— Dr. João Guerreiro, Technical Director

CHICAGO, ILLINOIS, UNITED STATES, March 26, 2020 / -- Chicago, IL: PreScouter, a Chicago-based research intelligence company has released two detailed reports centered around the COVID-19 pandemic. The first report provides a comprehensive overview of the current status of the epidemic, while the second report details the latest R&D efforts in place to potentially find a vaccine, treatment, or cure for the Novel Coronavirus. PreScouter sees these reports as a valuable resource in staying on top of the massive amounts of data and developments occurring each day.

Dr. João Guerreiro, co-author and PreScouter Technical Director for the healthcare and life sciences industry sees that the COVID-19 pandemic has been growing at such a speed that no region in the world will be left unaffected. “Perhaps, as surprising as the spread of the virus is, the answer from the research community is equally as surprising. Both academia and pharma got to work in such a short time! The first genome was sequenced the day after WHO declared a public health emergency. SARS took over 1 month! The collaboration and use of AI tools allowed for equally unprecedented speed in finding targets and potential drugs. The first human clinical trials started within weeks instead of months of the outbreak,” adds Dr. Guerreiro.

The first of the reports presents basic epidemiologic and biologic information on the SARS-CoV-2 virus aka COVID-19 and details the current standards for treatment, diagnostics, and prevention. The second report takes a deep dive into SARS-CoV-2 virus genetics and the strategies and tools that fueled the identification of new therapies. PreScouter researchers also look into some of the latest research and treatments being developed. Both reports are free to download and view.

About PreScouter, Inc.: PreScouter provides research support services to help business leaders make better R&D, product development and corporate development decisions. PreScouter’s custom-selected teams of Advanced Degree Researchers and Subject Matter Experts connect business leaders with new markets, commercializable technologies, industry-impacting startups, and other actionable data. PreScouter’s growing list of 500+ clients includes GE Healthcare, Coca Cola, BAE Systems, Abbvie, and Volvo. For more info, please visit

Mariam Jomha
+1 872-222-9225
email us here

Powered by EIN Presswire

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release